|
| Friday, October 16, 2020 |
|
|
TOT BIOPHARM International Company Limited Optimises Company Management Structure to Promote Strategic Development Upgrade |
| TOT BIOPHARM International Company Limited ("TOT BIOPHARM" or the "Company"; stock code: 1875.HK), is pleased to announce that Ms. Yeh-Huang, Chun-Ying, Executive Director, has been appointed as Vice Chairman of the Board while she has resigned as General Manager of the Company. more info >> |
|
| Wednesday, April 22, 2020 |
|
|
TOT BIOPHARM Self-Developed Biological Drug TAB008 (Pusintin) Meets Primary Endpoint in Phase III Clinical Trial |
| TOT BIOPHARM International Company Limited ("TOT BIOPHARM" or the "Company"; stock code: 1875.HK) is pleased to announce that the randomized Phase III clinical trial of TAB008 (Pusintin) has recently reached the predefined primary endpoint. more info >> |
|
| Wednesday, March 18, 2020 |
|
|
東曜藥業宣佈2019年全年業績 |
| 東曜藥業股份有限公司（「東曜藥業」或「公司」；股票代碼：1875.HK）－ 專注於創新型腫瘤藥物及療法的臨床階段生物製藥公司，今天欣然宣佈其截至2019年12月31日止年度（「年內」）之經審核全年業績。 more info >> |
|
|
TOT BIOPHARM Announces 2019 Annual Results |
| TOT BIOPHARM International Company Limited ("TOT BIOPHARM" or the "Company"; stock code: 1875.HK), a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative oncology drugs and therapies, announced today its audited annual results for the year ended 31 December 2019. more info >> |
|
| Monday, March 9, 2020 |
|
|
TOT BIOPHARM Garners "Listing Award of Technological Company" and "Innovative Technological Research and Development Award" |
| On 6 March 2020, a morale-enhancing conference themed "Working Towards a World-class High-tech ePark & a New Summit for Reform and Opening-up in the New Era" was held at Suzhou Industrial Park more info >> |
|
|
東曜藥業榮獲科技企業上市獎和科技研發突出獎 |
| 2020年03月06日，蘇州工業園區召開「建設世界一流高科技園區 打造新時代改革開放新高地」誓師大會。 more info >> |
|
| Thursday, January 2, 2020 |
|
|
新年喜訊第一彈！東曜藥業（1875.HK）生物藥研發獲納入國家「重大新藥創制」科技重大專項 |
| 東曜藥業股份有限公司（「東曜藥業」或「公司」；股票代碼：1875.HK）欣然宣佈， 公司收到國家衛生健康委醫藥衛生科學發展研究中心下發的《關於重大新藥創制科技重大專項2019年度實施計劃立項課題的通知》（衛科專項函(2019)764號）。 more info >> |
|
|
TOT BIOPHARM Biological Drug R&D Project Makes List of National Major Scientific and Technological Special Projects for "Significant New Drug Development" |
| TOT BIOPHARM International Company Limited ("TOT BIOPHARM" or the "Company"; stock code: 1875.HK) is pleased to announce that the Company has received notice of Project Topics of 2019 Implementation Plan of Major Special Technology Projects for "Significant New Drug Creation" more info >> |
|
| Monday, December 16, 2019 |
|
|
東曜藥業獲納入「蘇州工業園區2019年度上市獎勵企業」名單 |
| 東曜藥業股份有限公司（「東曜藥業」或「公司」；股票代碼：1875.HK）欣然宣佈，公司作為蘇州工業園區高新技術企業，於今年11月8日成功於港交所主板上市，因此受惠蘇州工業園區金融管理服務局對上市企業的支持，獲納入「蘇州工業園區2019年度上市獎勵企業及獎勵金額」名單，授予獎勵金額人民幣 400萬元。 more info >> |
|
|
TOT BIOPHARM Included in the "Suzhou Industrial Park - 2019 Awarded Listed Enterprises" |
| TOT BIOPHARM International Company Limited ("TOT BIOPHARM" or the "Company"; stock code: 1875.HK) is pleased to announce that the Company, a high-tech enterprise located in the Suzhou Industrial Park, was successfully listed on the Main Board of the Stock Exchange of Hong Kong on 8 November this year. more info >> |
|
|
|
|
